References

Aboody, K.S., J. Najbauer, M.Z. Metz, M. D'Apuzzo and M. Gutova et al., 2013. Neural stem cell-mediated enzyme/prodrug therapy for glioma: Preclinical studies. Sci. Transl. Med., Vol. 5. 10.1126/scitranslmed.3005365

Ahmed, A.U., M.A. Tyler, B. Thaci, N.G. Alexiades, Y. Han, I.V. Ulasov and M.S. Lesniak, 2011. A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. Mol. Pharm., 8: 1559-1572.
CrossRef  |  

Bexell, D., A. Svensson and J. Bengzon, 2013. Stem cell-based therapy for malignant glioma. Cancer Treat. Rev., 39: 358-365.
CrossRef  |  

Cao, X., Y. Gu, L. Jiang, Y. Wang and F. Liu et al., 2013. A new approach to screening cancer stem cells from the U251 human glioma cell line based on cell growth state. Oncol. Rep., 29: 1013-1018.
CrossRef  |  

Dietrich, J., E.L. Diamond and S. Kesari, 2010. Glioma stem cell signaling: Therapeutic opportunities and challenges. Expert Rev. Anticancer Ther., 10: 709-722.
CrossRef  |  Direct Link  |  

Filatova, A., T. Acker and B.K. Garvalov, 2013. The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment. Biochimica Biophysica Acta (BBA)-Gen. Subj., 1830: 2496-2508.
CrossRef  |  Direct Link  |  

Firat, E., A. Weyerbrock, S. Gaedicke, A.L. Grosu and G. Niedermann, 2012. Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote γ-irradiation-induced cell death in primary stem-like glioma cells. PLoS ONE, Vol. 7. 10.1371/journal.pone.0047357

Frosina, G., 2011. Stem cell-mediated delivery of therapies in the treatment of glioma. Mini Rev. Med. Chem., 11: 591-598.
CrossRef  |  

Gao, X., J.T. McDonald, L. Hlatky and H. Enderling, 2013. Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res., 73: 1481-1490.
CrossRef  |  Direct Link  |  

Gao, Z., P. Cheng, Y. Xue and Y. Liu, 2012. Vascular endothelial growth factor participates in modulating the C6 glioma-induced migration of rat bone marrow-derived mesenchymal stem cells and upregulates their vascular cell adhesion molecule-1 expression. Exp. Ther. Med., 4: 993-998.
CrossRef  |  

Guvenc, H., M.S. Pavlyukov, K. Joshi, H. Kurt and Y.K. Banasavadi-Siddegowda et al., 2013. Impairment of glioma stem cell survival and growth by a novel inhibitor for Survivin-Ran protein complex. Clin. Cancer Res., 19: 631-642.
CrossRef  |  Direct Link  |  

He, H., M.W. Li and C.S. Niu, 2012. The pathological characteristics of glioma stem cell niches. J. Clin. Neurosci., 19: 121-127.
CrossRef  |  

Heddleston, J.M., M. Hitomi, M. Venere, W.A. Flavahan and K. Yang et al., 2011. Glioma stem cell maintenance: The role of the microenvironment. Curr. Pharm. Des., 17: 2386-2401.
CrossRef  |  PubMed  |  

Hu, Y., P. Cheng, Y.X. Xue and Y.H. Liu, 2012. Glioma cells promote the expression of vascular cell adhesion molecule-1 on bone marrow-derived mesenchymal stem cells: a possible mechanism for their tropism toward gliomas. J. Mol. Neurosci., 48: 127-135.
CrossRef  |  

Hua, W., Y. Yao, Y. Chu, P. Zhong and X. Sheng et al., 2011. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma. J. Neuro-Oncol., 105: 149-157.
CrossRef  |  

Ji, B., Q. Chen, B. Liu, L. Wu, D. Tian, Z. Guo and W. Yi, 2013. Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma. Yonsei Med. J., 54: 92-100.
CrossRef  |  

Jin, X., Y.W. Sohn, J. Yin, S.H. Kim and K. Joshi et al., 2013. Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27^KIP1 and MMP3 expression. Cancer Lett., 328: 235-242.
CrossRef  |  

Lee, E.X., D.H. Lam, C. Wu, J. Yang, C.K. Tham, W.H. Ng and S. Wang, 2011. Glioma gene therapy using induced pluripotent stem cell derived neural stem cells. Mol. Pharm., 8: 1515-1524.
CrossRef  |  

Lee, H.K., S. Finniss, S. Cazacu, E. Bucris and A. Ziv-Av et al., 2013. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget, 4: 346-361.
PubMed  |  

Marsh, J.C., J.A. Wendt, A.M. Herskovic, A. Diaz, B.T. Gielda and R.W. Byrne, 2012. High-grade glioma relationship to the neural stem cell compartment: A retrospective review of 104 cases. Int. J. Radiation Oncol. Biol. Phys., 82: e159-e165.
CrossRef  |  

Mo, L.J., H.X. Ye, Y. Mao, Y. Yao and J.M. Zhang, 2013. B7-H4 expression is high in human U251 glioma stem-like cells and is induced in monocytes cultured in U251 stem-like cell conditioned medium. Chin. J. Cancer, 32: 653-660.
CrossRef  |  PubMed  |  

Morgan, R.A., L.A. Johnson, J.L. Davis, Z. Zheng and K.D. Woolard et al., 2012. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma. Hum. Gene Ther., 23: 1043-1053.
CrossRef  |  

Sun, L., Z. Wu, Y. Shao, Y. Pu and W. Miu et al., 2012. MicroRNA-34a suppresses cell proliferation and induces apoptosis in U87 glioma stem cells. Technol. Cancer Res. Treat., 11: 483-490.
CrossRef  |  PubMed  |  

Velpula, K.K., A.A. Rehman, B. Chelluboina, V.R. Dasari and C.S. Gondi et al., 2012. Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway. Cell. Signal., 24: 2076-2084.
CrossRef  |  

Xu, Q., X. Yuan and J.S. Yu, 2012. Glioma Stem Cell Research for the Development of Immunotherapy. In: Glioma: Immunotherapeutic Approaches (Advances in Experimental Medicine and Biology, Volume 746), Yamanaka, R. (Ed.). Springer, New York, USA., ISBN-13: 9781461431459, pp: 216-225.

Yang, X.J., W. Cui, A. Gu, C. Xu and S.C. Yu et al., 2013. A novel zebrafish xenotransplantation model for study of glioma stem cell invasion. PLoS ONE, Vol. 8. 10.1371/journal.pone.0061801

Ying, Z., Y. Li, J. Wu, X. Zhu and Y. Yang et al., 2013. Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype. Cancer Res., 73: 990-999.
CrossRef  |